
    
      The trial consists of two cohorts:

        -  Cohort A, patients without an indication for OAC prior to TAVI.

        -  Cohort B, patients with an indication for OAC prior to TAVI (eg. atrial fibrillation,
           mechanic mitral valve prosthesis).
    
  